whether the FDA needs to further restrict or ban the use of Rezulin (troglitazone) for diabetes
April 1999
Experts are questioning whether the FDA needs to further restrict or ban the use of Rezulin (troglitazone) for diabetes. ...
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote